ATLAS fair value
$547.70
Below fair value · 62% discount
Nutex Health stock price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · NASDAQ
Prices as of Oct 27, 2026 · USD
$547.70
Below fair value · 62% discount
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Nutex Health's fair value at about $547.70 per share (reasonable range: $477.02 to $746.78). At $207.80, the stock trades 62% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Nutex Health a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $181.66 and $230.95; in 9 out of 10, between $146.83 and $285.73. Estimated annual volatility is 54%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Nutex Health sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks NUTX has traded between $83.99 and $226.16. Today it is 8.1% below that high and 147% above its low.
On the business: revenue grew 82.4% year over year; net margin is 20.6%; it trades at 8.2 times earnings.
Its beta is 2.02: it tends to move more than the market, both up and down.
Nutex Health Inc. is a healthcare management and operations company that provides care delivery and support services through its Hospital Division and Population Health Management Division.
Want to see everything about Nutex Health?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About $547.70 per share according to ATLAS (reasonable range: $477.02 to $746.78). With the stock at $207.80, it is 62% below it.
47%: close to a coin flip. In half of the simulated outcomes, NUTX ends the month between $181.66 and $230.95.
Nutex Health's market capitalization is $1.5B. Its price-to-earnings (P/E) ratio is 8.2: you pay $8.2 for each $1 of yearly earnings.
ATLAS estimates annual volatility at 54%. In a typical month, half of the outcomes end between $181.66 and $230.95.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy